Allison Harrigan
Senior Director Corporate Development·RA Capital Management
Bio
Professional summary
Allison Harrigan is Senior Director of Corporate Development at Raven, RA Capital's company-creation platform, where she focuses on new company creation. Before Raven, she was Executive Director of Strategy and Business Development at a stealth neuroscience biotech company and held corporate strategy roles at Valo Health. Earlier, she worked at McKinsey serving pharmaceutical and biotech clients and began her career at the National Institutes of Health in a drug discovery group focused on rare and neglected diseases.
Background
Career, education, and skills
Career history
- Raven / RA Capital ManagementSenior Director Corporate Development2024 – Present
- Stealth neuroscience biotech companyExecutive Director of Strategy and Business Development2022 – 2023
- Valo HealthDirector of Corporate Strategy and other strategy roles2019 – 2022
- McKinsey & CompanyConsultant
- National Institutes of HealthResearcher, drug discovery group
Education
- MIT Sloan School of ManagementMBA
- Georgetown UniversityBS in Chemistry
Other partners at RA Capital Management
12 more profiles
Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.
Breanna O'Reilly
Analyst
RA Capital Management
Investment analyst focused on biotech due diligence.